In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate Hassan Shaikh for a discussion on noteworthy developments relating to the IRA and drug pricing.
Together, Bridgette and Hassan explore:
The expansion and evolution of the Medicare Drug Price Negotiation ProgramCourt challenges to the Negotiation ProgramDrug pricing reform and the OBBBAImpacts on patients and hospitals related to Medicare Part D, 340B, and OPPS clawbacksThe rise of direct-to-consumer drug sales modelsBridgette and Hassan cut through the complexity and provide an overview of these topics, which are covered in greater depth in the Q3 2025 Edition of the Mintz IRA Update.